JPMorgan Chase & Co. Cuts Spire Healthcare Group (LON:SPI) Price Target to GBX 303

Key Points

• JPMorgan Chase & Co. has lowered its price target for Spire Healthcare Group from GBX 309 to GBX 303, while maintaining an "overweight" rating.
• Berenberg Bank also reaffirmed a "buy" rating on Spire Healthcare, setting a price target of GBX 280.
• Spire Healthcare's stock opened at GBX 207.65, indicating a potential upside of 45.92% from JPMorgan's revised target.

Spire Healthcare Group (LON:SPI - Get Free Report) had its price target dropped by equities researchers at JPMorgan Chase & Co. from GBX 309 ($4.16) to GBX 303 ($4.08) in a research report issued to clients and investors on Tuesday, MarketBeat reports. The firm presently has an "overweight" rating on the stock. JPMorgan Chase & Co.'s target price would suggest a potential upside of 41.26% from the stock's previous close.

Separately, Berenberg Bank reaffirmed a "buy" rating and set a GBX 280 ($3.77) price target on shares of Spire Healthcare Group in a report on Thursday, July 31st.

Spire Healthcare Group Trading Up 0.7%

Shares of SPI traded up GBX 1.50 ($0.02) during midday trading on Tuesday, hitting GBX 214.50 ($2.89). 523,476 shares of the stock were exchanged, compared to its average volume of 1,331,104. Spire Healthcare Group has a 52-week low of GBX 168.20 ($2.26) and a 52-week high of GBX 260.50 ($3.50). The stock has a fifty day simple moving average of GBX 217.02 and a 200 day simple moving average of GBX 205.95. The firm has a market cap of £861.37 million, a P/E ratio of 30.53, a P/E/G ratio of 1.06 and a beta of 0.96. The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70.

Spire Healthcare Group (LON:SPI - Get Free Report) last released its earnings results on Thursday, July 31st. The company reported GBX 4.10 ($0.06) earnings per share (EPS) for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, research analysts anticipate that Spire Healthcare Group will post 15.6634747 EPS for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.